» Articles » PMID: 7607784

Changes in Cerebrospinal Fluid Levels of Malondialdehyde and Glutathione Reductase Activity in Multiple Sclerosis

Overview
Specialty Pharmacology
Date 1994 Jan 1
PMID 7607784
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

The chemical composition of human cerebrospinal fluid (CSF) is considered to reflect brain metabolism. In this study we measured malondialdehyde (MDA) levels and the activity of enzymes involved in antioxidative processes, glutathione reductase and glutathione peroxidase, in human cerebrospinal fluid of multiple-sclerosis (MS) patients and normal healthy volunteers. Our results indicated that the cerebrospinal fluid in MS showed significantly higher endogenous levels of MDA than the control, as well as a much greater resistance to in-vitro stimulation test. In addition, we found the activity of GSH reductase significantly increased, about twice the control values, whereas the activity of glutathione peroxidase was markedly decreased as compared to control values. Our findings suggest that in MS the activity of antioxidant enzymes is modified, and indicates the conceivable possibility of a pathogenic role of oxidative stress in the determinism of the disease.

Citing Articles

Carboxymethyllysine and carboxyethyllysine in multiple sclerosis patients.

Damasiewicz-Bodzek A, Labuz-Roszak B, Kumaszka B, Tyrpien-Golder K Arch Med Sci. 2024; 20(3):736-742.

PMID: 39050184 PMC: 11264072. DOI: 10.5114/aoms.2020.95654.


Oxidative Stress Markers in Multiple Sclerosis.

Jimenez-Jimenez F, Alonso-Navarro H, Salgado-Camara P, Garcia-Martin E, Agundez J Int J Mol Sci. 2024; 25(12).

PMID: 38927996 PMC: 11203935. DOI: 10.3390/ijms25126289.


Ferroptosis induces detrimental effects in chronic EAE and its implications for progressive MS.

Jhelum P, Zandee S, Ryan F, Zarruk J, Michalke B, Venkataramani V Acta Neuropathol Commun. 2023; 11(1):121.

PMID: 37491291 PMC: 10369714. DOI: 10.1186/s40478-023-01617-7.


Overview of the Neuroprotective Effects of the MAO-Inhibiting Antidepressant Phenelzine.

Matveychuk D, MacKenzie E, Kumpula D, Song M, Holt A, Kar S Cell Mol Neurobiol. 2021; 42(1):225-242.

PMID: 33839994 PMC: 8732914. DOI: 10.1007/s10571-021-01078-3.


Monitoring the Redox Status in Multiple Sclerosis.

Tanaka M, Vecsei L Biomedicines. 2020; 8(10).

PMID: 33053739 PMC: 7599550. DOI: 10.3390/biomedicines8100406.